Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)

The summary for the Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed): The purpose of this limited competition Funding Opportunity Announcement (FOA) is to continue support for the Center for International Blood and Marrow Transplant Research (CIBMTR) as a data resource enabling broad studies on Hematopoietic Stem Cell transplantation (HCT) and Adoptive Cellular Therapy (ACT) research. The CIBMTR represents a network comprised of more than 380 US and international transplant centers that submit outcome data for patients receiving cellular therapies. The CIBMTR Statistical Center provides data acquisition and management and information technology services to maintain a unique contemporary clinical outcomes' database and facilitates observational and interventional research through scientific and statistical expertise necessary to support analyses of these data. NIH is supporting the CIBMTR to ensure the database remains available to the public and to improve the treatment, survival, and quality of life for patients diagnosed with cancer and non-malignant blood disorders.
Federal Grant Title: Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-CA-22-026
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.395, 93.839, 93.855
CFDA Descriptions: Information not provided
Current Application Deadline: September 15th, 2022
Original Application Deadline: September 15th, 2022
Posted Date: June 14th, 2022
Creation Date: June 14th, 2022
Archive Date: October 21st, 2022
Total Program Funding:
Maximum Federal Grant Award: $5,500,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: June 14th, 2022
Applicants Eligible for this Grant
Small businesses
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. Please see Full Announcement for additional details on eligibility
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-22-026.html
Grant Announcement Contact
NIH OER Webmaster
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not A...
Assay development and screening for discovery of chemical probes, drugs or immunomodulator...
Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Mino...
Cancer Adoptive Cellular Therapy Network (Can-ACT) for Pediatric Cancers (UG3/UH3 Clinical...
Single Source: Pediatric Early Phase Clinical Trials Network (PEP-CTN; UM1 Clinical Trial ...
Breast and Prostate Cancer Data Quality and Patterns of Care Study
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies in Adults
National Cooperative Drug Discovery Groups for Cancer
More Grants from the National Institutes of Health
New Investigator Gateway Awards for Collaborative T1D Research (R03 Clinical Trial Not All...
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
NIA Predoctoral Fellowship Award to Promote Broad Participation in Translational Research ...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2025 FederalGrants.com